Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 17/20 | 0.37 |
| ▸ | MME | P08473 | 12/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | AGTR2 | P50052 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL841065 | 0.91 | MEN1 (0.39) | AGTR1MEN1KMT2AAGTR2GAA | |
| SCHEMBL839507 | 0.91 | MEN1 (0.39) | AGTR1MEN1KMT2AAGTR2GAA | |
| SCHEMBL839095 | 0.90 | MEN1 (0.41) | AGTR1MMEMEN1KMT2AGAA | |
| SCHEMBL839269 | 0.90 | AGTR1 (0.40) | AGTR1MME | |
| SCHEMBL839257 | 0.89 | AGTR1 (0.37) | AGTR1MMEAGTR2 | |
| SCHEMBL841047 | 0.89 | MMP8 (0.41) | MEN1KMT2A | |
| SCHEMBL839870 | 0.88 | AGTR1 (0.40) | AGTR1MMEAGTR2 | |
| SCHEMBL839993 | 0.88 | SLC6A4 (0.37) | AGTR1MME | |
| SCHEMBL840167 | 0.88 | MLNR (0.39) | AGTR1MMEMEN1KMT2A | |
| SCHEMBL840951 | 0.88 | AGTR1 (0.40) | AGTR1MMEAGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8143298-B2 | Dual-acting antihypertensive agents | THERAVANCE, INC. (US) | 2012-03-27 | — | — | US | disclosed |